Has Bolaji Nafiu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,706 in general payments to Bolaji Nafiu, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bolaji Nafiu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bolaji Nafiu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bolaji Nafiu, MD

Vascular Surgery · Wildomar, CANPI 1003927393

Payments from drug & device makers

$8,706in general payments, 2019–2025

Across 143 payments — averaging $60.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Silk Road Medical, Inc.$2K
Penumbra, Inc.$1K
Angiodynamics, Inc.$1K
Medtronic$466
Cardiovascular Systems Inc.$420
Inari Medical, Inc.$415
plus $3K from 27 others

What the payments were for

Travel & lodging$2,03323%
Food & beverage$6,56875%
Education$1051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Silk Road Medical, Inc.	15	$1,903
Penumbra, Inc.	2	$1,400
Angiodynamics, Inc.	22	$1,108
Medtronic	8	$466
Cardiovascular Systems Inc.	16	$420
Inari Medical, Inc.	6	$415
Boston Scientific	17	$402
Johnson & Johnson(2 entities)	10	$346
Abbott	6	$246
Cumberland Pharmaceuticals, Inc.	4	$245
Veryan Medical Incorporated	2	$234
Shockwave Medical, Inc	2	$206
Cordis US CORP.	4	$191
AstraZeneca	1	$125
Abiomed	1	$118
Stryker	3	$101
Cagent Vascular Inc	1	$101
Innocoll Pharmaceuticals Limited	2	$88
Argon Medical Devices, Inc.	2	$83
Prytime Medical Devices, Inc.	1	$80
Covidien LP	1	$61
Kerecis Limited	2	$58
Acell, Inc.	2	$56
Integra Lifesciences Corporation	2	$43
Cook Medical LLC	2	$43
Alphatec Spine, Inc	1	$33
Lemaitre Vascular, Inc.	2	$32
Endologix LLC	1	$23
Philips North America LLC	1	$21
BD	1	$19
Olympus America Inc.	1	$15
Tactile Systems Technology Inc	1	$14
Venclose Inc.	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENROUTE Transcarotid Neuroprotection System$1,864
Indigo System$1,400
ENROUTE Transcarotid Stent System$1,073
ENHANCE Transcarotid Peripheral Access Kit$1,073
ENROUTE 0.014 Guidewire$1,073
Auryon Laser System 100-120 Vac$633
ENROUTE Transcarotid Stent$550
FLOWTRIEVER CATHETER, S$297
CT THROMBECTOMY SYSTEM KIT$297
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$241
BioMimics 3D Vascular Stent System$234
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$186
Signia$163
Mynx Venous VCD$132
ANDEXXA$125
XARELTO$125
Varithena Administration Pack$116
Caldolor$103
Serrantor$101

How this compares

$8,706 in reported general payments places this provider in the 65th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024

$242,835

Medicare patients

220

Services billed

582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	48	$501
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$129

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Wildomar

Venita ChandraPalo Alto$947K
Leigh Ann ObanionFresno$932K
Sukgu HanLos Angeles$765K
Mahmoud Malasla Jolla$508K
Son DuongFountain Valley$503K
Leo FongClovis$496K
Jason LeePalo Alto$403K
Bernardo Curi MendesLos Angeles$376K
Trevor DerderianRancho Mirage$359K
Karthikeshwar KasirajanPalo Alto$349K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →